In this Q&A, Marty Becker, DVM, Elite FFCP-V and Paul Bloom, DVM, DACVD, DABVP (Canine and Feline), Elite FFCP-III share ...
The global atopic dermatitis treatment market is on the cusp of remarkable expansion, with projections indicating a surge in ...
Boulder-based Enveda Biosciences, which uses machine learning to discover naturally occurring drug compounds, plans to begin testing ENV-294, its leading drug candidate developed to treat atopic ...
Long-term treatment with lebrikizumab may be beneficial for patients with atopic dermatitis that were not initially ...
AD, The most common inflammatory skin disorder worldwide, is a highly heterogeneous condition with current treatments that do ...
Data from a retrospective multicenter study, along with a review of previous trials, supported the real-world utility of ...
Arcutis Biotherapeutics is going long with the latest push for its seborrheic dermatitis treatment Zoryve. | Arcutis ...
Comment by Feb. 17 for your feedback to be reviewed by the guideline development workgroup.
FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.
A small cohort study found that a wearable hand sensor that uses artificial intelligence reduced subconscious nighttime ...
Apogee begins patient dosing in Part B of phase 2 APEX trial of APG777 to treat moderate-to-severe atopic dermatitis: San Francisco Tuesday, February 4, 2025, 18:00 Hrs [IST] Apog ...
For children with atopic dermatitis (AD), early childhood stressful life events are associated with an increased risk for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback